The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo

Journal of Virology

Volumn 74, Issue 19, 2000, Pages 9115-9124

  Merchant, M ^a   Caldwell, R G ^a   Longnecker, R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN; LATENT MEMBRANE PROTEIN 2A; MEMBRANE PROTEIN; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME BINDING; EPSTEIN BARR VIRUS; GENE EXPRESSION; LYMPHOBLASTOID CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIRUS CELL TRANSFORMATION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMAL; B-LYMPHOCYTES; BASE SEQUENCE; CELL TRANSFORMATION, VIRAL; HERPESVIRUS 4, HUMAN; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; RECEPTORS, IMMUNOLOGIC; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRAL MATRIX PROTEINS;

EID: 0033808329     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.19.9115-9124.2000     Document Type: Article

References (81)

1. EBV persistence in memory B cells in vivo
2. Epstein-Barr virus related lymphoepithelioma-like carcinoma of lung
3. Detection of Epstein-Barr virus in invasive breast cancers
4. Epstein-Barr virus genotypes in NPC biopsies from North Africa
5. A complex of Grb2 adaptor protein, Sos exchange factor, and a 36-kDa membrane-bound tyrosine phosphoprotein is implicated in ras activation in T cells
6. Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EμLMP2A transgenic mice
7. Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals
8. Signal transduction from the B cell antigen-receptor
9. Lymphocyte signalling: A coordinating role for Vav?
10. Tyrosine phosphorylation of phospholipase C induced by membrane immunoglobulin in B lymphocytes
11. Specific association of Epstein-Barr virus with lymphoepithelial carcinoma among tumors and tumorlike lesions of the salivary gland
12. A subpopulation of normal B cells Intently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1
13. Syk tyrosine kinase required for mouse viability and B-cell development
14. Cross-linking of surface Ig receptors on murine B lymphocytes stimulates the expression of nuclear tetradecanoyl phorbol acetate-response element-binding proteins
15. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4
16. Direct targets of phosphoinositide 3-kinase products in membrane traffic and signal transduction
17. Syk and Bruton's tyrosine kinase are required for B ceil antigen receptor-mediated activation of the kinase Akt
18. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav
19. Functional independence and interdependence of the Src homology domains of phospholipase C-γ1 in B-cell receptor signal transduction
20. Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals
21. Downstream signalling events regulated by phosphatidylinositol 3-kinase activity
22. LMP2 function in EBV Latency
23. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction
24. The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction
25. Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein-Barr virus latency
26. BLNK: A central linker protein in B cell activation
27. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach
28. Protein kinase Cθ, a selective upstream regulator of JNK/SAPK and IL-2 promoter activation in Jurkat T cells
29. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase
30. IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function
31. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation
32. Epstein-Barr virus-associated typical gastric carcinoma detected by in situ hybridization and polymerase chain reaction
33. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK - Functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling
34. Tyrosine phosphorylation of phospholipase C-gamma 2 upon cross-linking of membrane Ig on murine B lymphocytes
35. EBV gene expression in an NPC-related tumour
36. The Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A) PY motif recruits WW domain-containing ubiquitin-protein ligases
37. BLNK required for coupling Syk to PLC gamma 2 and Racl-JNK in B cells
38. Different protein tyrosine kinases are required for B cell antigen receptor-mediated activation of extracellular signal-regulated kinase, c-Jun NH2-terminal kinase 1, and p38 mitogen-activated protein kinase
39. Epstein-Barr virus and its replication
40. Genetic analysis of B cell antigen receptor signaling
41. Molecular dissection of B cell antigen receptor signaling
42. Epstein-Barr virus in epithelial cell tumors: A breast cancer study
43. In vivo ablation of surface immunoglobulin on mature B ceils by inducible gene targeting results in rapid cell death
44. Epstein-Barr virus and malignant lymphoepithelial lesions of the salivary gland
45. Guanine-nucleotide-releasing factor hSosl binds to Grb2 and links receptor tyrosine kinases to Ras signalling
46. Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases
47. Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2
48. Molecular biology of Epstein-Barr virus
49. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase
50. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1
51. Regulation of Epstein-Barr virus latency by latent membrane protein 2
52. The only domain which distinguishes Epstein-Barr virus latent membrane 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro, and LMP2A is therefore nonessential
53. The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro
54. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B
55. 2+ signals in human B cells
56. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases
57. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking
58. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes
59. Induction of early response genes by cross-linking membrane Ig on B lymphocytes
60. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
61. Activation of phospholipase C in human B cells is dependent on tyrosine phosphorylation
62. Epstein-Barr virus and nasopharyngeal carcinoma
63. Epstein-Barr virus infection in carcinoma of the salivary gland
64. Epstein-Barr virus
65. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients
66. Differential activation and regulation of mitogen-activated protein kinases through the antigen receptor and CD40 in human B cells
67. Two related Epstein-Barr virus membrane proteins are encoded by separate genes
68. PtdIns-3,4,5-P3: A regulatory nexus between tyrosine kinases and sustained calcium signals
69. The mechanism of action of cyclosporin A and FK506
70. Negative staining EM for the detection of Epstein-Barr virus in oral hairy leukoplakia
71. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-gamma 2
72. 2+ mobilization through distinct pathways
73. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state
74. Jun-B gene expression mediated by the surface immunoglobulin receptor of primary B lymphocytes
75. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk
76. Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes
77. Phosphatidylinositol 3-kinase-dependent membrane association of the Bruton's tyrosine kinase pleckstrin homology domain visualized in single living cells
78. Cyclosporin-A sensitive induction of NF-AT in murine B cells
79. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells
80. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease